Rare diseases
Investigational molecules
Locations
Back to Denmark37 clinical trials in Holbæk, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study on Preventing Blood Infections in Hemodialysis Patients Using Amoxicillin/Clavulanic Acid or Clindamycin
DenmarkStudy Comparing Meropenem and Piperacillin/Tazobactam for Adults with Sepsis
DenmarkStudy on Reducing Cardiovascular Disease in Type 1 Diabetes Patients Using Finerenone and Semaglutide
DenmarkStudy on the Effect of Influenza Vaccine on Preserving Beta Cell Function in Early Type 1 Diabetes Patients
DenmarkStudy on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis
DenmarkStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
DenmarkRosuvastatin zinc 20 mg for patients with cardiovascular disease and statin intolerance: a trial comparing continuation after a 36‑week N‑of‑1 self‑assessment versus standard care
DenmarkA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
DenmarkA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
DenmarkStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
DenmarkStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
DenmarkStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on heart failure prevention and innovative treatments for atrial fibrillation. Multiple trials are evaluating new therapeutic combinations and medications for improved patient outcomes.
Research includes novel approaches using baxdrostat and dapagliflozin combinations for heart failure risk reduction.
Comprehensive research into chronic kidney disease treatments, particularly focusing on patients with concurrent hypertension. Studies examine innovative therapeutic approaches for non-diabetic kidney disease.
Trials investigate combined therapies to slow disease progression and improve patient outcomes.
Innovative trials addressing obesity management in different age groups, with special attention to adolescent populations. Studies also focus on diabetes treatment approaches.
Research includes novel treatments with semaglutide for weight management in young populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
